Atlas Trials

MediciNova

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MediciNova

RecordFirmDate
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia (NCT05464784)MediciNova2022-08-22
Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS (NCT04429555)MediciNova2021-01-11
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS (NCT04057898)MediciNova2020-05-28
Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers (NCT04054206)MediciNova2019-06-24
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma (NCT03782415)MediciNova2018-12-29
Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers (NCT03533387)MediciNova2018-04-11

Track MediciNova automatically

Every clearance here is in the API, with alerts when new ones post.